 |
- Must Attend for Heads of Business Development, Sales and Marketing – Positioning branded generics to preserve and grow market share
- Dr Jang Kyung-Won from Korea Health Industry Development Institute, the organization spearheading ASEAN Harmonization, will be presenting on the region’s latest moves towards unified regional regulation
- Examine increasing moves by originators venturing into greater collaborations and partnerships with Asia’s incumbent generic players
- More NEW speakers and MAJOR companies sharing their views and experience including:
- Yariv Hefez , Director Global Business Development & Alliance Management, Merck Serono (Switzerland)
- Song Jun , Business Development Manager, Strategy & Business Development, Pfizer
- Dr Deepak Murpani, Vice President, Product Development¸ Genepharm Group (Greece)
- Khalid Mahmood , Managing Director & Chief Executive Officer, Getz Pharma (Pvt) Limited (Pakistan)
- Jamaludin Elis , Commercial Director, Pharmaniaga Marketing Sdn Bhd (Malaysia)
- Explore differentiated generics, generics plus, supergenerics – commercialization and if it is more than a marketing gimmick
- Tap “pharmerging” growth and where the greatest risks and gains lie
- Debate ongoing patent wars between originators and generic companies
- Find out how to win the confidence and brand equity from Asian prescribers and patients
|
|
 |
Choose Your Language |
 |
|
|
|
Produced by |
|
|
|
|
Supporting Association |
|
|
|
|
International Marketing Partner |
|
|
|
|
